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Abstract
Mutations in the voltage-gated sodium channels
SCN1A and SCN2A are responsible for several types
of human epilepsy. Variable expressivity among
family members is a common feature of these
inherited epilepsies, suggesting that genetic modifi-
ers may influence the clinical manifestation of epi-
lepsy. The transgenic mouse model Scn2aQ54 has an
epilepsy phenotype as a result of a mutation in Scn2a
that slows channel inactivation. The mice display
progressive epilepsy that begins with short-duration
partial seizures that appear to originate in the hip-
pocampus. The partial seizures become more fre-
quent and of longer duration with age and often
induce secondary generalized seizures. Clinical
severity of the Scn2aQ54 phenotype is influenced by
genetic background. Congenic C57BL/6J.Q54 mice
exhibit decreased incidence of spontaneous seizures,
delayed seizure onset, and longer survival in com-
parison with [C57BL/6J · SJL/J]F1.Q54 mice. This
observation indicates that strain SJL/J carries domi-
nant modifier alleles at one or more loci that deter-
mine the severity of the epilepsy phenotype.
Genome-wide interval mapping in an N2 backcross
revealed two modifier loci on Chromosomes 11 and
19 that influence the clinical severity of of this so-
dium channel-induced epilepsy. Modifier genes
affecting clinical severity in the Scn2aQ54 mouse
model may contribute to the variable expressivity
seen in epilepsy patients with sodium channel
mutations.
Introduction
Mutations in voltage-gated sodium channels associ-
ated with human epilepsy were first identified in the
disorder Generalized Epilepsy with Febrile Seizures
Plus (GEFS+) (Wallace et al. 1998; Escayg et al. 2000).
GEFS+ is a heterogeneous syndrome in which af-
fected family members have febrile seizures in
childhood which may progress to other seizure types
later in life. More than 150 mutations in the sodium
channels SCN1A and SCN2A have been identified in
human patients (reviewed in Meisler and Kearney
2005). The variable expressivity among family
members with the same primary mutation suggests
that the clinical severity depends on secondary fac-
tors which may include genetic modifiers.
We have developed a mouse model with a mis-
sense mutation of Scn2a, designated Scn2aQ54, with
an epilepsy phenotype that resembles human patients
(Kearney et al. 2001). Scn2aQ54 mice express a trans-
gene in which expression of the Scn2aGAL879881QQQ
cDNA (abbreviated Scn2aQ54) is driven by the neuron-
specific enolase (NSE) promoter. The mutation
GAL879-881QQQ in the cytoplasmic S4-S5 linker of
domain 2 results in delayed channel inactivation and
increased persistent current when measured in
Xenopus oocytes and in hippocampal neurons from
Scn2aQ54 transgenic mice (Smith and Goldin 1997;
Kearney et al. 2001). The level of persistent current in
Scn2aQ54 neurons (2% of total peak current) is
comparable to that produced by mutations such as
SCN1AR1648H in families with GEFS+ (Lossin et al.
2002).
Scn2aQ54 transgenic mice exhibit progressive
epilepsy that begins at 6-8 weeks of age with recur-
rent, spontaneous partial seizures that appear to
originate in the hippocampus (Kearney et al. 2001).
The electrographic seizures are accompanied by epi-
sodes of behavioral arrest, tonic deviation of the head
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and body, and forelimb clonus (Kearney et al. 2001).
Scn2aQ54 transgenic mice exhibit hippocampal
pathology that resembles human mesial temporal
lobe epilepsy with neuron loss in areas CA1 and CA3
and in the hilus of the dentate gyrus (Kearney et al.
2001). The GEFS+ spectrum includes temporal lobe
epilepsy (Abou-Khalil et al. 2001). Line C57BL/6J.Q54
was established by backcrossing a (C57BL/6J·SJL/J)F2
founder to strain C57BL/6J. Offspring from the first
and second backcross generations (N1 and N2) were
used to characterize the phenotype described in
Kearney et al. (2001). Twelve percent to 25% of the
genome of these mice is derived from strain SJL/J.
We have established the congenic line C57BL/
6J.Q54 (abbreviated B6.Q54) by ten generations of
backcrossing to strain B6. This line is estimated to
contain less than 0.1% of SJL-derived DNA (Silver
1995). We describe a strain difference in the
Scn2aQ54 phenotype between the congenic B6.Q54
line and the (B6 · SJL/J)F1 background. This suggests
that strain SJL/J carries alleles at one or more mod-
ifier loci that increase the incidence and severity of
seizures caused by the Scn2aQ54 mutation. We report
the results of analysis of an N2 backcross that reveals
two modifier loci that influence epilepsy suscepti-
bility due to a sodium channel mutation.
Materials and methods
Mice. Scn2aQ54 transgenic mice (TgN54Mm) were
generated by microinjection of (C57BL/6J · SJL/J)F2
oocytes as described (Kearney et al. 2001). The con-
genic line C57BL/6J.Q54 (abbreviated B6.Q54) was
established by ten successive generations of back-
crossing to strain C57BL/6J and is maintained by
continued backcrossing of hemizygous transgenic
males to C57BL/6J females. Strain SJL/J was crossed
to B6.Q54 to generate (B6.Q54 · SJL)F1 offspring. For
mapping, (B6.Q54 · SJL)F1 mice were backcrossed to
strain C57BL/6J. SJL/J (stock No. 00686) and C57BL/
6J (stock No. 00064) mice were obtained from The
Jackson Laboratory (Bar Harbor, ME). The double-
ridge (dblr) mouse mutant was identified in a screen
for insertional mutants and found to be caused by a
transgene insertion on the SJL/J-derived Chromo-
some 19 of the founder (MacDonald et al. 2004). The
incipient congenic line B6.dblr with the interval of
Chromosome 19 containing the SJL/J-derived dblr
mutation has been backcrossed to C57BL/6J for eight
generations and is estimated to contain less than 2%
of SJL-derived DNA (Silver 1995).
Phenotyping. Mice were genotyped for the Q54
transgene on postnatal day 14. Nontransgenic mice
were discarded. Scn2aQ54 transgenic mice were ob-
served for visible seizures during 30-min observation
periods at various ages. N2 backcross mice were ob-
served for 30-min sessions at 3 and 6 weeks of age.
Observations were performed between 1:00 and 4:00
pm in a temperature- and humidity-controlled room.
Mice were transferred to a clean observation cage (7 34
in. W · 12 in. D · 6 12 in. H) just before the obser-
vation session. Assessment of visible seizures was
based on prior video-EEG monitoring that demon-
strated coincident behavioral and EEG abnormalities
(Kearney et al. 2001).
Genotyping. DNA was prepared from tail biop-
sies by phenol:chloroform extraction and ethanol
precipitation. Q54 transgene-positive mice were
identified by PCR with primers in exon 4 and exon 5
of Scn2a (Q54F-5¢-GCAAGGGGCTTTTGTCTAG
AAG-3¢ and Q54R-5¢-TCAATGCTCGGAGAACTC
TGAACG-3¢). These primers amplify a 715-bp
genomic product from the endogenous Scn2a gene
and a 151-bp product from the Scn2aQ54 cDNA
transgene. Genome-wide microsatellite genotyping
services were provided by the Center for Inherited
Disease Research (CIDR, http://www.cidr.jhmi.edu/
mouse/mouse_strp.html). (CIDR is fully funded
through a federal contract from the National Insti-
tutes of Health to The Johns Hopkins University,
Contract Number N01-HG-65403.) Additional mi-
crosatellite genotyping was performed by analysis of
PCR products on 7% nondenaturing polyacrylamide
gels stained with ethidium bromide or an ABI 3730
Automated Sequencer (Applied Biosystems, Foster
City, CA) in The University of Michigan DNA
Sequencing Core (Robert Lyons, Director, http://
seqcore.brcf.med.umich.edu). SNP genotyping was
performed by analysis of PCR products by confor-
mation-sensitive gel electrophoresis (CSGE) as de-
scribed (Plummer et al. 1998) or by sequencing. The
dblr and Dkk1+/) mice were genotyped as described
(MacDonald et al. 2004).
Genetic analysis. Association between geno-
types and the presence of epilepsy at each locus was
first assessed by single-marker analysis using logistic
regression, wherein the significance of shifts in
allelic proportions was determined by an odds-ratio
test. We then used interval mapping, using a maxi-
mum-likelihood procedure designed for categorical
traits (Galecki et al. 2001). We refer to this method
as categorical trait interval mapping (CTIM). CTIM
takes as its underlying model an example of a
latent class model in which a categorical (here,
dichotomous) phenotype is treated as a function of
both the unknown (unobservable) genotype at a
putative marker and the known (observable) geno-
684 S.K. BERGREN ET AL.: GENETIC MODIFIERS AFFECTING SEVERITY OF EPILEPSY
type at flanking markers. Under this model each
probability defining the joint distribution of pheno-
type data and unobservable genotypes (complete
data) is decomposed into the product of two under-
lying probabilities: Prob(phenotype|unobservable
genotype) · Prob(unobservable genotype). Compo-
nent probabilities are then modeled using logistic
regression and Haldanes mapping function, respec-
tively. This model may also be considered an elab-
oration of generalized linear models, with a
composite link function applied to odds ratios and
binomial distribution (McCullagh and Nelder 1989).
This methodology implemented in Preisser et al.
(2000) and Ayyadevara et al. (2003) uses maximum-
likelihood calculations implemented with SAS
module PROC NLIN, with a separate SAS macro
that allows permutation test calculations. A work-
ing version of PROC NLIN code is available at
http://www-personal.umich.edu/agalecki/ via a
link to ‘‘CTIM: a set of SAS macros for categorical
trait interval mapping.’’
Significance of single-marker peaks can be eval-
uated in terms of the expected incidence of false
positives (type I errors). In single-marker analysis,
the LOD score (and corresponding v2) threshold for
an experiment-wise a value of 0.05 (i.e., a 5% chance
of obtaining at least one association of marker to
trait, purely by chance, anywhere in the genome )
was estimated empirically (Churchill and Doerge
1994) by determining the v2 statistics for each mar-
ker over 1000 permutations of the trait category as-
signed to each genotype.
Candidate gene screening. Positional candidate
genes were identified from the publicly available
mouse genome sequence (www.ensembl.org) and
selected by tissue expression and gene function.
Primers were designed using Oligo Primer Analysis
software (ver. 6.65, Molecular Biology Insights,
Cascade, CO). Genes were amplified from B6 and SJL
by RT-PCR or by PCR of exon sequence from geno-
mic DNA. PCR products were gel-purified and se-
quenced on an ABI 3730 Automated Sequencer in
The University of Michigan DNA Sequencing Core
Facility. Sequences were compared using Sequen-
cher software (GeneCodes, Ann Arbor, MI).
Results
Effect of genetic background. Scn2aQ54 transgenic
mice were generated by microinjection of (C57BL/6J
· SJL/J)F2 eggs as previously described (Kearney et al.
2001). The initial characterization used mice from
the first (N1) and second (N2) C57BL/6J backcross
generations with 12%25% of the genome derived
from strain SJL/J (Kearney et al. 2001). We have
carried out ten successive generations of backcross-
ing to transfer the Scn2aQ54 transgene onto the
C57BL/6J background, establishing the congenic line
C57BL/6J.Q54 (abbreviated B6.Q54). This line is
estimated to contain less than 0.1% of SJL/J-derived
DNA (Silver 1995). The phenotype of the congenic
line was found to be much less severe than in the N1
and N2 mice, with low incidence, delayed onset and
reduced severity of seizures, and increased longevity.
To determine whether the reduced severity re-
sulted from loss of SJL/J alleles at modifier loci, we
crossed the B6.Q54 congenic mice to strain SJL/J.
The resulting (SJL · B6)F1.Q54 offspring (abbreviated
F1.Q54) were genotyped at P14 and observed in 30-
min sessions at 3, 4.5, and 6 weeks of age. A com-
parison of the phenotype in F1.Q54 and B6.Q54 mice
is presented in Fig. 1. F1.Q54 mice exhibited high
incidence of seizures (>80%) with early onset
(Fig. 1A). In contrast, B6.Q54 mice exhibited a low
incidence of seizures, with less than 20% having
seizures at 3 months of age (Fig. 1A). Affected F1
animals have a high seizure frequency of 8-16 per 30
min, while seizure frequency is low in the small
number of B6.Q54 mice that exhibit seizures
(Fig. 1B). Fewer than 25% of F1.Q54 mice survive to 6
months of age compared with greater than 75% of
the congenic B6.Q54 mice (Fig. 1C). The data indi-
cate that strain SJL/J carries alleles at one or more
loci that influence susceptibility to epilepsy caused
by the Scn2a mutation.
Backcross mapping of modifier loci. To localize
loci responsible for the strain difference in seizure
susceptibility between B6.Q54 and F1.Q54 mice, we
carried out a backcross of F1.Q54 mice to strain
C57BL/6J. Backcross progeny carrying the Scn2aQ54
transgene were examined by visual observation for
30 min at 3 and 6 weeks of age. Mice that exhibited
one or more seizures during the 30-min observation
were classified as ‘‘susceptible’’ and mice without
seizures as ‘‘resistant.’’ Among 150 backcross ani-
mals there were 46 susceptible and 104 resistant
individuals. The deviation from a 1:1 ratio (v2 = 22.4,
p < 2.1e)6) indicates that there is more than one lo-
cus responsible for the phenotype difference between
strains. This seizure incidence in the N2 backcross
population is intermediate between the parental
strains (Fig. 3).
A 20-cM-resolution genome scan, including 90
microsatellite markers with an average spacing of
14.9 cM, was carried out on 79 backcross DNAs,
including 38 susceptible and 41 resistant. Genotyp-
ing of additional N2 animals was performed on
chromosomes with significant association by single-
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marker analysis. The Scn2aQ54 transgene insertion
site was localized to mouse Chromosome 1 between
58 and 70 cM (94103 Mb), reducing the ability to
detect modifiers on this chromosome.
Modifier loci affecting epilepsy susceptibility
resulting from a sodium channel mutation were
mapped using CTIM analysis. The genome-wide
significance threshold of p = 0.05 corresponding to
a LOD score of 2.6 was determined with 1000
permutations of the trait data with respect to ob-
served genotypes. CTIM analysis provided sugges-
tive or significant evidence for two modifier loci on
Chromosomes 11 and 19 (Fig. 2). The locus on
Chromosome 11, designated Moe1 (modifier of
epilepsy 1), peaks at 54 cM (95 Mb). Inheritance of
an SJL allele at this locus confers increased resis-
tance. Among the resistant N2 mice, 67% (53/80;
v2 = 8.45, p < 0.004) inherited an SJL allele at
D11Mit289. The locus on Chromosome 19 desig-
nated Moe2 peaks at 24 cM (31.3 Mb) and inheri-
tance of an SJL allele at this locus confers increased
susceptibility. Among the susceptible N2 mice,
67% (31/46; v2 = 5.57, p < 0.02) inherited an SJL
allele at D19Mit135. No significant epistatic
interactions were detected between Moe1 or Moe2
and other loci in the genome.
The combined effect of Moe1 and Moe2 accounts
for approximately 80% of the difference in seizure
incidence between B6.Q54 and F1.Q54 mice. Inheri-
tance of three susceptible alleles, including two B6
alleles at Moe1 and an SJL allele at Moe2, results in
seizure incidence approaching that of the F1.Q54
mice (Fig. 3). Conversely, inheritance of one sus-
ceptible allele and three resistant alleles at these loci
(Moe1BS, Moe2BB) results in seizure incidence simi-
lar to B6.Q54 mice (Fig. 3).
Chromosome 19 interval-specific strain. The
B6.dblr mouse strain carries an SJL/J-derived seg-
ment of Chromosome 19 that spans the Moe2 1-LOD
support interval from D19Mit86 to D19Mit88
(Fig. 4A). The dblr mutation was caused by a trans-
gene insertion with a 60-kb intergenic deletion of
mouse Chromosome 19, resulting in decreased
expression of the Wnt signaling inhibitor Dkk1
(MacDonald et al. 2004). Mice homozygous for the
Fig. 1. Severity of epilepsy in F1.Q54 and B6.Q54 mice.
A. Incidence of seizures in F1.Q54 and B6.Q54 mice at 13
months of age. B. Average number of seizures in F1.Q54
and B6.Q54 mice at 3, 4.5, and 6 weeks of age (*p < 1e)9).
C. Reduced lifespan in F1.Q54 mice compared with that of
B6.Q54.
Fig. 2. Genome-wide interval mapping for epilepsy sus-
ceptibility due to a sodium channel mutation. The Y axis
indicates the LOD score. Horizontal lines mark the sig-
nificance thresholds for genome-wide suggestive
(LOD = 1.4, p < 0.63; dashed line) and significant
(LOD = 2.6, p < 0.05; solid line) evidence of linkage based
on 1000 permutations of the data. The X axis is in centi-
morgans with chromosome numbers indicated below.
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dblr mutation have defects in forelimb development
(Adamska et al. 2003). Heterozygous dblr/+ mice do
not display spontaneous seizures or increased sus-
ceptibility to seizures induced by pentylenetetrazol
(40 and 50 mg/kg i.p.) (data not shown).
To confirm the mapping of the Moe2 locus on
Chromosome 19, we crossed B6.dblr/+ mice with
B6.Q54 mice. Offspring were genotyped for
Scn2aQ54, the dblr mutation, and the microsatellite
markers D19Mit86, D19Mit135, and D19Mit133.
Scn2aQ54 transgene-positive offspring underwent 30-
min observations for spontaneous seizures at 3, 4.5,
and 6 weeks of age. B6.Q54 mice carrying the SJL-
derived dblr interval of Chromosome 19 exhibited a
higher incidence of spontaneous seizures than
B6.Q54 mice (v2 = 8.3, p < 0.004) (Fig. 4B). The in-
creased incidence of seizures in (B6.Q54, dblr/+)
mice supports the mapping of Moe2 to Chromosome
19.
To test the effect of reduced levels of Dkk1 on
seizure susceptibility, we crossed B6.Q54 mice with
Dkk1+/) null heterozygotes (Mukhopadhyay et al.
2001). (B6.Q54, Dkk1+/)) mice do not exhibit in-
creased seizure incidence compared with the
(B6.Q54, Dkkl+/+) littermates (data not shown),
indicating that reduced expression of Dkk1 does not
account for the increased seizure susceptibility of
(B6.Q54, dblr/+) mice.
Positional candidate genes. The Moe1 and
Moe2 regions were examined for strong candidate
genes in the publicly available mouse genome se-
quence (www.ensembl.org). In the Moe1 region of
Chromosome 11, candidate genes included two in-
wardly rectifying potassium channels (Kcnj2,
Kcnj16) and seizure-related gene 6 (Sez6). In the
Moe2 region on Chromosome 19, candidate genes
included a high-affinity glutamate transporter
(Slc1a1), a serotonin receptor (Htr7), the very-low-
density lipoprotein receptor (Vldlr), and two tumor
suppressor genes that have been associated with
seizures in mice (Pten) (Backman et al. 2001) and
human patients (Lgi1) (Kalachikov et al. 2002). We
screened for coding sequence polymorphisms in
these candidate genes by RT-PCR or by PCR of ex-
Fig. 3. Combined effect of Moe1 and Moe2 on the inci-
dence of seizures in backcross offspring. Backcross animals
were grouped according to the number of susceptible al-
leles inherited at the peak markers of the Moe1
(D11Mit289) and Moe2 (D19Mit135) loci. Susceptible al-
lele: Moe1B, Moe2S. The incidence of seizures for each
group is shown. The overall bar represents seizure inci-
dence in the backcross population without grouping by





Fig. 4. Effect of an SJL-derived interval of Chromosome 19
on epilepsy phenotype in B6.Q54 congenic mice. A. Map of
Chromosome 19 showing the SJL/J-derived interval in dblr
mice. The SJL/J-derived interval is shown in black. Gray
denotes the interval containing the recombination. B.
Incidence of seizures in offspring of B6.Q54 mice crossed
to B6.dblr/+ mice. Mice with the SJL-derived interval of
Chromosome 19 are indicated as (Q54, dblr/+) and litter-
mates that are B6 in the interval are indicated as (Q54, +/+)
(*p < 0.004).
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onic sequence from B6 and SJL genomic DNA. No
coding sequence polymorphisms were observed.
Regulation of expression was not evaluated.
Discussion
We report an effect of strain background on the
severity of epilepsy caused by a sodium channel
mutation. Genetic analysis of an N2 backcross
identified two modifier loci that influence the
severity of epilepsy in Scn2aQ54 mice. This is in
agreement with previous studies that have shown
seizure susceptibility and severity to be under ge-
netic influence (Frankel et al. 1995; Ferraro et al.
1997, 1999; Legare et al. 2000; Legare and Frankel
2000; Ferraro et al. 2001, 2002, 2004).
The phenotyping of mice in our mapping back-
cross divided animals into two categories based on
the presence or absence of seizures. The categorical
nature of our data precluded the use of conventional
interval mapping procedures which assume that trait
data are continuous and normally distributed.
Methods for analysis of such data include nonpara-
metric interval mapping, which makes no assump-
tions about the distribution of the trait data
(Kruglyak and Lander 1995), and categorical traits
interval mapping (CTIM), which is a Bayesian max-
imum-likelihood procedure for analysis of categori-
cal traits (Galecki et al. 2001). Ayyadevara et al.
(2003) performed a direct comparison of nonpara-
metric interval mapping and CTIM in a study of
lifespan of C. elegans. They found that both methods
yielded consistent results but observed sharper peaks
with CTIM mapping resulting in smaller 95% con-
fidence intervals and assert that CTIM represents a
more appropriate statistical model for categorical
trait data (Ayyadevara et al. 2003).
Loci responsible for strain differences in sus-
ceptibility to seizures induced by handling, kainate,
pentylenetetrazol, and electroconvulsive shock have
been mapped to specific mouse chromosomes
(Frankel et al. 1995; Ferraro et al. 1997, 1999; Legare
et al. 2000; Legare and Frankel 2000; Ferraro et al.
2001, 2002, 2004). QTLs influencing seizure-induced
cell death have also been mapped in strains C57BL/
6J (resistant) and FVB/N (susceptible) (Schauwecker
et al. 2004). Previous studies have shown that strain
C57BL/6J is resistant to seizures induced by a variety
of methods, including chemoconvulsants, electro-
convulsive shock, audiogenic, and handling (Seyfried
et al. 1980; Ferraro et al. 1997, 1999, 2001; Frankel
et al. 2001; Ferraro et al. 2002; Kitami et al. 2004).
Little has been reported about the seizure suscepti-
bility of strain SJL/J. However, the limited reports on
SJL and the demonstrated susceptibility of the clo-
sely related strain FVB/NJ suggest that SJL is likely
to be on the susceptible end of the spectrum (Frankel
et al. 2001; Golden et al. 2001; Chen et al. 2005).
A major-effect seizure susceptibility QTL (des-
ignated Szs1) has been mapped to distal Chromo-
some 1 by studies of strain differences in
susceptibility to seizures induced by kainate, pen-
tylenetetrazol, and maximal electroshock (Ferraro
et al. 1997, 1999, 2001, 2002, 2004). Ferraro et al
(2004) suggested that the potassium channel Kcnj10
variant T262S is a likely candidate for Szs1. In sup-
port of this, a significant association was demon-
strated between seizure resistance and the variant
R271C in the human ortholog KCNJ10 (Buono et al.
2004). In our N2 backcross, Szs1 segregated inde-
pendent of seizure phenotype, indicating that it does
not contribute to the observed difference in epilepsy
severity between strains B6 and SJL.
Two previous studies identified seizure suscep-
tibility QTLs on Chromosome 11 in regions over-
lapping the Moe1 locus. QTL mapping in the
epilepsy-susceptible EL mouse strain identified the
locus El6 on Chromosome 11 at which homozygos-
ity for the allele from the resistant DDY/Jcl strain
confers increased susceptibility to seizures (peak 68
cM) (Frankel et al. 1995). The QTL Szs3 was mapped
to the same region in a study of kainate-induced
seizure susceptibility in strains DBA/2J and C57BL/
6J (peak 66 cM). Homozygosity of the Szs3 allele
from the resistant B6 strain at this locus confers
increased susceptibility to seizures (Ferraro et al.
1997). In our study, Moe1 maps to the same region,
and homozygosity for the allele from the resistant B6
strain also confers increased epilepsy susceptibility,
suggesting that Szs3 and Moe1 may reflect the effect
of the same B6 allele.
The epilepsy susceptibility locus Moe2 on
Chromosome 19 was confirmed by using a congenic
mouse strain with this interval derived from strain
SJL/J. We used the B6.dblr mouse strain with an SJL-
derived interval on Chromosome 19. This provided a
useful resource for confirmation of the Moe2 locus,
circumventing the need to generate an interval-spe-
cific congenic strain. Compared with littermates
without the SJL-derived Chromosome 19 interval,
(B6.Q54, dblr/+) mice had increased seizure inci-
dence. The mutation in heterozygous dblr/+ mice
results in a 20% reduction in expression of the Wnt
inhibitor Dkk1 (MacDonald et al. 2004). As a control
for the effect of reduced Dkk1 expression, a hetero-
zygous null allele of Dkk1 with a 50% reduction in
Dkk1 expression did not influence the epilepsy
phenotype of Scn2aQ54 mice. This supports the
hypothesis that the increased epilepsy susceptibility
is a result of the SJL-derived interval of Chromosome
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19. This region of Chromosome 19 has not been
associated with seizure susceptibility or severity in
previous QTL studies and represents a novel epilepsy
susceptibility locus.
The 1-LOD support interval of the Moe1 locus
on Chromosome 11 contains more than 500 known
and predicted genes and the Moe2 locus contains
more than 150 known and predicted genes. Likely
candidate genes include ion channels, receptors,
neurotransmitters and neuromodulators, transcrip-
tion factors, and genes involved in neural develop-
ment and injury response. Polymorphisms that
result in changes in protein sequence or variants in
regulatory elements are likely to underlie the genetic
difference in seizure susceptibility between strains.
Large-scale copy number polymorphisms are another
type of variation whose role in genetic diversity is
just beginning to be appreciated (Sebat et al. 2004).
We screened the coding sequence of a small number
of candidate genes but did not identify any coding
polymorphisms.
More than 150 mutations in voltage-gated so-
dium channels have been identified in patients with
epilepsy. Variable expressivity is a common feature
of inherited epilepsy caused by sodium channel
mutations because family members with the same
mutation exhibit differences in the clinical severity
of epilepsy. For example, in one GEFS+ family car-
rying the K1270T mutation in SCN1A, nine family
members had isolated febrile seizures and five family
members have TLE (Abou-Khalil et al. 2001). In an-
other family with the T875M mutation in SCN1A,
half of the family members had isolated febrile sei-
zures while the other half had more severe seizure
types including generalized tonic-clonic, absence,
atonic, and hemicorporeal seizures (Moulard et al.
1999; Escayg et al. 2000). This variable expressivity
suggests that other factors besides the primary so-
dium channel mutation influence the clinical man-
ifestation of epilepsy in human patients. This could
include stochastic events during development,
accumulation of somatic mutations (Weiss 2005),
environmental insults such as trauma, and differ-
ences in inheritance of genetic susceptibility alleles
such as these mapped in the current study. Isolation
of susceptibility genes and analysis of the underlying
pathophysiology will contribute to understanding
the molecular events of epileptogenesis and identify
novel therapeutic targets.
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